Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_assertion description "[In a multivariate model, promoter methylation of the cyclin-dependent kinase inhibitor 2A gene p16, the H-cadherin gene CDH13, the Ras association domain family 1 gene RASSF1A, and the adenomatous polyposis coli gene APC in tumors and in histologically tumor-negative lymph nodes was associated with tumor recurrence, independently of NSCLC stage, age, sex, race, smoking history, and histologic characteristics of the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_assertion evidence source_evidence_curated NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_assertion SIO_000772 18337602 NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_assertion wasDerivedFrom ctd_human-20150221 NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_assertion wasGeneratedBy ECO_0000218 NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP9887.RAqis0ooHoQ9HynldzRJ9yEsfwa5ylM560aRB_NZYm4ms130_provenance.